Response by Unlu et al to Letter Regarding Article, "Polypharmacy in Older Adults Hospitalized for Heart Failure".
作者信息
Unlu Ozan, Levitan Emily B, Maurer Mathew S, Safford Monika M, Lachs Mark S, Goyal Parag
机构信息
Department of Medicine (O.U.), Weill Cornell Medicine, New York, NY.
Department of Epidemiology, University of Alabama at Birmingham (E.B.L.).
出版信息
Circ Heart Fail. 2021 Mar;14(3):e008305. doi: 10.1161/CIRCHEARTFAILURE.121.008305. Epub 2021 Mar 12.
Abstract
摘要
相似文献
1
Response by Unlu et al to Letter Regarding Article, "Polypharmacy in Older Adults Hospitalized for Heart Failure".Unlu等人对关于“因心力衰竭住院的老年人多重用药”一文的信件的回复。
Circ Heart Fail. 2021 Mar;14(3):e008305. doi: 10.1161/CIRCHEARTFAILURE.121.008305. Epub 2021 Mar 12.
2
Letter by Cogswell et al Regarding Article, "Polypharmacy in Older Adults Hospitalized for Heart Failure".
Circ Heart Fail. 2021 Mar;14(3):e008160. doi: 10.1161/CIRCHEARTFAILURE.120.008160. Epub 2021 Mar 12.
3
Heart Failure Medical Management in 2020: Searching for the Right Polypharmacy.2020年心力衰竭的药物治疗：探寻合适的联合用药方案
Circ Heart Fail. 2020 Nov;13(11):e007779. doi: 10.1161/CIRCHEARTFAILURE.120.007779. Epub 2020 Oct 13.
4
Polypharmacy and taste disorders in heart failure patients.心力衰竭患者的多重用药与味觉障碍
Eur J Prev Cardiol. 2020 Jan;27(1):110-111. doi: 10.1177/2047487319856717. Epub 2019 Jun 14.
5
Attitudes of Patients and Prescribing Clinicians to Polypharmacy and Medication Withdrawal in Heart Failure.
J Card Fail. 2016 Sep;22(9):743-4. doi: 10.1016/j.cardfail.2016.05.004. Epub 2016 May 20.
6
Predictors of unplanned hospitalisation in the older population: The role of polypharmacy and other medication and chronic disease-related factors.老年人群计划外住院的预测因素：多重用药及其他与药物和慢性病相关因素的作用。
Australas J Ageing. 2020 Sep;39(3):e436-e446. doi: 10.1111/ajag.12769. Epub 2020 Feb 13.
7
Complex and Potentially Harmful Medication Patterns in Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭中的复杂且潜在有害的药物模式。
Am J Med. 2021 Mar;134(3):374-382. doi: 10.1016/j.amjmed.2020.07.023. Epub 2020 Aug 18.
8
The problem of polypharmacy in heart failure.心力衰竭中的多重用药问题。
Curr Cardiol Rep. 2006 May;8(3):217-25. doi: 10.1007/s11886-006-0037-7.
9
Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care.慢性心力衰竭中的共病与多重用药：一项在基层医疗中的大型横断面研究
Br J Gen Pract. 2017 May;67(658):e314-e320. doi: 10.3399/bjgp17X690533. Epub 2017 Apr 10.
10
Comorbidities and polypharmacy.共病与多种药物治疗
Heart Fail Clin. 2014 Apr;10(2):367-72. doi: 10.1016/j.hfc.2013.12.001.
本文引用的文献
1
Inclusion of Performance Parameters and Patient Context in the Clinical Practice Guidelines for Heart Failure.将性能参数和患者情况纳入心力衰竭临床实践指南。
J Card Fail. 2021 Feb;27(2):190-197. doi: 10.1016/j.cardfail.2020.09.473. Epub 2020 Oct 14.
2
Polypharmacy in Older Adults Hospitalized for Heart Failure.老年心力衰竭住院患者的多种药物治疗。
Circ Heart Fail. 2020 Nov;13(11):e006977. doi: 10.1161/CIRCHEARTFAILURE.120.006977. Epub 2020 Oct 13.
3
Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.患者报告的心血管药物停药障碍和促进因素。
Drugs Aging. 2020 Feb;37(2):125-135. doi: 10.1007/s40266-019-00729-x.
4
Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults.医师视角下老年人群心血管药物的逐渐减停。
J Am Geriatr Soc. 2020 Jan;68(1):78-86. doi: 10.1111/jgs.16157. Epub 2019 Sep 11.
5
Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future.老年心力衰竭的域管理方法：现状与未来。
J Am Coll Cardiol. 2018 May 1;71(17):1921-1936. doi: 10.1016/j.jacc.2018.02.059.
Zotero 插件